Analyst Upgrades

• Aetna (AET) to buy from neutral at Goldman.
• Kellogg (K) to buy from neutral at UBS.
• PetSmart (PETM) to outperform from market perform at JMP Securities.
• NetApp (NTAP) and Scripps Networks (SNI) to buy from hold at Wunderlich.
• Thoratec (THOR) to buy from hold at Auriga.
• ArcelorMittal (MT) to overweight from neutral at HSBC.
• Bristol-Myers (BMY) to outperform from neutral at Cowen.
• Eaton Vance (EV) to neutral from sell at Ticonderoga.
• Adtran (ADTN) to buy from underperform at BofA/Merrill.

Continue reading Analyst Calls: AET, BMY, DVN, GLW, K, MRK, MT, PETM, SPLS, WY ...

Analyst Calls: AET, BMY, DVN, GLW, K, MRK, MT, PETM, SPLS, WY ... originally appeared on BloggingStocks on Mon, 07 Feb 2011 11:40:00 EST. Please see our terms for use of feeds.

Analyst Calls

• Medtronic (MDT) to buy from neutral and 1-800-Flowers.com (FLWS) to neutral from sell at Goldman.
• CarMax (KMX) to outperform from perform at Oppenheimer.
• Points International (PTSEF) to buy from neutral at Merriman.
• Nokia (NOK) to market perform from underperform at Morgan Keegan.
• Amdocs (DOX) to overweight from equal weight at Barclays.
• Western Alliance (WAL) to outperform from sector perform at RBC Capital.
• Carbo Ceramics (CRR) to outperform from market perform at BMO Capital.
• Rackspace (RAX) to buy from hold at Benchmark Co.
• Brinker (EAT) to equal weight from underweight at Morgan Stanley.

Continue reading Analyst Calls: BP, EAT, JBLU, KMX, MDT, MYGN, NOK, NTRS, RAX, RDS.A, T ...

Analyst Calls: BP, EAT, JBLU, KMX, MDT, MYGN, NOK, NTRS, RAX, RDS.A, T ... originally appeared on BloggingStocks on Fri, 28 Jan 2011 11:20:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Thoratec (THOR) to buy from neutral at UBS.
• TW Telecom (TWTC) to buy from hold at Citigroup.
• TAL Education (XRS) to overweight from neutral at Piper Jaffray.
• Amedisys (AMED) to buy from hold at Deutsche Bank.

Analyst Downgrades

• Navigators (NAVG) to neutral from outperform at Macquarie.
• El Paso Electric (EE) to hold from buy at Jefferies.
• Hancock Holding (HBHC) to hold from buy at Wunderlich.
• California Water Service (CWT) and American States Water (AWR) to neutral from buy at Janney Capital.
• Mednax (MD) to hold from buy at Deutsche Bank.

Continue reading Analyst Calls: AMED, AMZN, CVC, DOLE, EL, EBAY, NWL, SBUX, THOR, UIS ...

Analyst Calls: AMED, AMZN, CVC, DOLE, EL, EBAY, NWL, SBUX, THOR, UIS ... originally appeared on BloggingStocks on Tue, 21 Dec 2010 11:20:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• DuPont (DD) was upgraded to buy from neutral at Goldman.
• UBS upgraded Deere (DE) to buy from neutral and AGCO (AGCO) to neutral from sell.
• Canadian Solar (CSIQ) was upgraded to outperform from neutral at Macquarie.
• Thoratec (THOR) and DTE Energy (DTE) were upgraded to overweight from equal weight at Barclays.
• NICE Systems (NICE) was upgraded to overweight from neutral at HSBC.
• Deutsche Bank upgraded Copa Holdings (CPA) to buy from hold.
• BofA/Merrill upgraded Nu Skin (NUS) to buy from neutral.
• Continental Resources (CLR) was upgraded to buy from hold at Jefferies.

Continue reading Analyst Calls: CLR, CSIQ, DD, DE, DECK, EMC, EMN, WFMI, WWW ...

Analyst Calls: CLR, CSIQ, DD, DE, DECK, EMC, EMN, WFMI, WWW ... originally appeared on BloggingStocks on Fri, 19 Nov 2010 12:00:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Intel (INTC) was upgraded to overweight from equal weight and Autodesk (ADSK) to equal weight from underweight at Morgan Stanley.
• Citigroup upgraded Blackrock (BLK) to buy from hold.
• 99c Only Stores (NDN) was upgraded to buy from hold at Deutsche Bank.
• PetSmart (PETM) was upgraded to overweight from equal weight at Barclays.
• Piper Jaffray upgraded Ruth's Hospitality (RUTH) and Morton's Restaurant (MRT) to overweight from neutral.
• BioMed Realty (BMR) was upgraded to market perform from underperform at FBR Capital.
• Wells Fargo upgraded Piedmont (PDM) to market perform from underperform.

Continue reading Analyst Calls: AA, AOL, BLK, CSCO, GOOG, INTC, JBL, JBLU, YHOO ...

Analyst Calls: AA, AOL, BLK, CSCO, GOOG, INTC, JBL, JBLU, YHOO ... originally appeared on BloggingStocks on Thu, 11 Nov 2010 12:00:00 EST. Please see our terms for use of feeds.

Continue reading Disney Set to Report Q4 Earnings

Disney Set to Report Q4 Earnings originally appeared on BloggingStocks on Wed, 10 Nov 2010 17:30:00 EST. Please see our terms for use of feeds.

Continue reading Disney Must Get Its Movie-Marketing House in Order

Disney Must Get Its Movie-Marketing House in Order originally appeared on BloggingStocks on Fri, 10 Sep 2010 09:00:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• RBC Capital upgraded Brookfield Infrastructure (BIP) to outperform from sector perform with a $20 target. The firm thinks the units' valuation is compelling, while the company's proposed acquisition of assets is positive.
• Stifel upgraded First Horizon (FHN) to buy from hold based on valuation and its path towards normalized profitability. The firm has a $15 price target on the stock.
• KeyBanc upgraded Isle of Capri (ISLE) to buy from hold based on improved earnings growth and valuation. The firm has a $13 target on the stock.
• ATA Inc. (ATAI) was upgraded to neutral from underweight at Piper Jaffray.
• Buckeye Partners (BPL) was upgraded to neutral from sell at Goldman.
• Sinopec (SNP) was upgraded to overweight from neutral at HSBC.

Continue reading Analyst Calls: ANN, BIP, DUK, FHN, ISLE, JCG, POM, RE, SMT ...

Analyst Calls: ANN, BIP, DUK, FHN, ISLE, JCG, POM, RE, SMT ... originally appeared on BloggingStocks on Tue, 24 Aug 2010 11:30:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Baird upgraded Visa (V) to outperform from neutral and raised its target to $100 from $88, citing valuation and an improvement in key trends that include transactions, volume and international travel.
• FBR Capital upgraded Illinois Tool Works (ITW) to outperform from market perform to reflect valuation and expectations for earnings upside in the first half of 2010. The firm raised its target on shares to $58 from $55.
• Goldman added Brookdale Senior Living (BKD) to its conviction buy list based on a bottom in fundamentals and positive senior housing trends. The firm raised its target to $22 from $20.
• Exxon Mobil (XOM) was upgraded to buy from hold at Societe Generale.
• Newfield Exploration (NFX) was upgraded to overweight from equal weight at Barclays.
• PPD (PPDI) was upgraded to buy from hold at Jefferies.

Continue reading Analyst upgrades, downgrades and initiations: AOL, BBT, ITW, THOR, TOT, V, XOM ...

Analyst upgrades, downgrades and initiations: AOL, BBT, ITW, THOR, TOT, V, XOM ... originally appeared on BloggingStocks on Mon, 14 Dec 2009 11:15:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Collins Stewart upgraded General Dynamics (NYSE: GD) to Buy from Hold as it finds the valuation compelling at current levels and sees potential upside from a better economy and better-than-expected defense budgets.
• SunTrust views the sell-off in shares of Cabot Oil (NYSE: COG) as a buying opportunity and expects the Pennsylvania Department of Environmental Protection order to be resolved quickly. The firm upgraded Cabot to Buy from Neutral.
• Barclays upgraded Cisco (NASDAQ: CSCO) to Overweight from Equal Weight based on expectations for improved carrier demand, continued U.S. momentum, and an improved Europe.
• Applied Materials (NASDAQ: AMAT) was upgraded to Buy from Hold at Citigroup.
• Stericycle (NASDAQ: SRCL) was upgraded to Gradually Accumulate from Hold at Soleil.
• Grupo Televisa (NYSE: TV) was upgraded to Neutral from Sell at Goldman.

Continue reading Analyst upgrades, downgrades and initiations: AMAT, CSCO, GD, HOT, LIZ, RBS ...

Analyst upgrades, downgrades and initiations: AMAT, CSCO, GD, HOT, LIZ, RBS ... originally appeared on BloggingStocks on Mon, 28 Sep 2009 10:30:00 EST. Please see our terms for use of feeds.

I keep watching Marvel Entertainment (NYSE: MVL), waiting (or maybe "hoping" would be the better term) for a great pullback to get in on the action. I never seem to get it. Who knows, maybe it'll happen later today. But as of Tuesday's close, Marvel was still above $40 per share after dropping less than 1%. And that was after the traders digested the company's Q2 earnings report. That, in my opinion, is telling.

Marvel has always been the kind of stock that can throw you for a loop. I know, because I've owned it before. Is it me, or is the market getting increasingly comfortable with the company's business model of taking risk in the movie industry? Maybe it's too early to tell. At any rate, according to the press release, Marvel saw big decreases in both sales and per-share income. The top line dropped 26%, while the bottom line fell 37% to 37 cents per share. Marvel beat earnings estimates by 6 cents per share according to Reuters.

Continue reading Marvel tops estimates, but decline in licensing sales pulls down profit

Marvel tops estimates, but decline in licensing sales pulls down profit originally appeared on BloggingStocks on Wed, 05 Aug 2009 09:00:00 EST. Please see our terms for use of feeds.

• Thomas Weisel upgraded SanDisk (NASDAQ: SNDK) to Overweight from Market Weight due to accelerating manufacturing cost declines, potential NAND flash sourcing upside at Toshiba (OTC: TOSBF) and Samsung and an increase in 2H09 demand.
  
• Oppenheimer upgraded Quality Systems (NASDAQ: QSII) to Perform from Underperform to reflect potential benefits from the stimulus package and channel checks that indicated IT budgets are stabilizing. The firm raised its target price on shares to $54 from $40.
  
• RBC Capital upgraded OSI Pharmaceuticals (NASDAQ: OSIP) to Outperform from Sector Perform following positive Tarceva survey results and cites valuation.
• Marriott (NYSE: MAR) was upgraded to Outperform from Market Perform at JMP Securities.
  
• Grainger (NYSE: GWW) was upgraded to Buy from Neutral at BofA/Merrill.
  
• Duncan Energy Partners (NASDAQ: DEP) was upgraded to Buy from Neutral at UBS.

Continue reading Analyst upgrades, downgrades and initiations: SNDK, POT, BK, ASIA ...

Analyst upgrades, downgrades and initiations: SNDK, POT, BK, ASIA ... originally appeared on BloggingStocks on Mon, 13 Jul 2009 11:45:00 EST. Please see our terms for use of feeds.

Thoratec (NASDAQ: THOR), known for its ventricular assist devices (VADs) for patients suffering late-stage heart failure, recently bought Australia's HeartWare. Investors responded positively to this move because it brings new technology to Thoratec and expands the company's already significant market share.

THOR currently has 85% of the U.S. heart pump market and 65% of Europe's, and this new technology could ensure THOR stays on the top of this market for at least the next five to 10 years. The Thoratec-HeartWare partnership has the potential to grow into a multibillion-dollar business, which will translate to big sales and earnings growth.

Continue reading Small-cap stock #5: Thoratec (THOR)

Small-cap stock #5: Thoratec (THOR) originally appeared on BloggingStocks on Sun, 17 May 2009 14:00:00 EST. Please see our terms for use of feeds.

Small-cap stocks are a GREAT place to start if you're serious about rebuilding your wealth and securing your financial future.

But what makes small-cap stocks so spectacular?

The bear market stripped analysts from small stocks -- hardly anyone is covering them anymore. This creates wonderful pricing anomalies and gives the individual investor a significant edge.

Continue reading 5 small-cap stocks to buy now

5 small-cap stocks to buy now originally appeared on BloggingStocks on Sat, 16 May 2009 09:00:00 EST. Please see our terms for use of feeds.

Marvel Entertainment (NYSE: MVL), whose colleagues include Sony (NYSE: SNE), News Corp. (NASDAQ: NWS), and Viacom (NYSE: VIA), issued its first-quarter report on Tuesday.

The market liked what it saw. That's because the comic-book concern beat analyst estimates by a pretty significant margin. Hey, what else would you expect from the company that brought you Iron Man?

Marvel delivered 57 cents per share in income. According to analysts, Wall Street was hoping for 37 cents per share. Quite a surprise.

Continue reading Marvel beat estimates in Q1 -- is its stock set to fly to new heights?

Marvel beat estimates in Q1 -- is its stock set to fly to new heights? originally appeared on BloggingStocks on Wed, 06 May 2009 14:00:00 EST. Please see our terms for use of feeds.

In The Oberweis Report, growth expert Jim Oberweis. Jr. sees upside for risk-oriented investors in two diagnostics firms: Myriad Genetics (NASDAQ: MYGN) and Thoratec (NASDAQ: THOR).

"Myriad develops molecular diagnostic products focused in the area of predictive caner diagnostics. It currently sells five genetic tests (and just recently announced the launch of a 6th test in December) focused on cancer and women's health.

"The bulk of their revenues currently come from their BRACAnalysis test for breast cancer. This test is the only one of its kind available to detect a faulty version of BRAC genes in women, which has been linked to significantly increased chances of developing breast and ovarian cancers.

Continue reading Diagnostics duo: Myriad (MYGN) and Thoratec (THOR)

Diagnostics duo: Myriad (MYGN) and Thoratec (THOR) originally appeared on BloggingStocks on Tue, 17 Mar 2009 10:30:00 EST. Please see our terms for use of feeds.

Marvel (NYSE: MVL) is a great company. It's got a lot of cool characters in its vast comic book portfolio. Spider-Man, Hulk, X-Men, you know them all. And it's a fun stock to both invest in and trade. It's a more direct play on movies than a Disney (NYSE: DIS) or a Time Warner (NYSE: TWX) is. I've made money on Marvel in the past. I don't currently own it, so I was pretty interested when I heard that Wedbush Morgan issued an upgrade this week.

Wedbush Morgan basically said that the market is undervaluing Marvel's potential. It sees a price target of $31. I myself think Marvel will break $30 yet again, but the problem I have is with sentiment. Exactly how will the market react to Marvel's shares this year?

Continue reading Is Marvel worthy of an upgrade?

Is Marvel worthy of an upgrade? originally appeared on BloggingStocks on Wed, 18 Feb 2009 09:45:00 EST. Please see our terms for use of feeds.

First off, both are great companies. No, not every move they make is perfect (example: Marvel still can't properly monetize its Incredible Hulk property with a decent film). But both stocks have held up relatively well, in my opinion, during the financial implosion. Both stocks are also below their respective 52-week high's and above their respective 52-week low's. That's not a bad position to be in (although I should point out that I generally would like to get these two around their 52-week low's). But which stock has the edge?

Well, Marvel's shares have been strong lately. According to the AOL quote at the time of this writing, Marvel is in the green in all time frames (year-to-date, one-month, one-year, etc.). DreamWorks Animation is in the red in a couple spots, but for the most part, it's been performing somewhat similarly to Marvel. I don't really see that much of a difference in terms of strength. Plus, both are arguably essentially equal in terms of valuation (at least in my opinion).

Continue reading DreamWorks Animation versus Marvel Entertainment: Which one is a buy?

DreamWorks Animation versus Marvel Entertainment: Which one is a buy? originally appeared on BloggingStocks on Wed, 07 Jan 2009 12:14:00 EST. Please see our terms for use of feeds.

Well, I've finally done it. I sold my entire position of Marvel Entertainment (NYSE: MVL). It wasn't an easy decision.

When I covered Marvel's latest earnings report, I alluded to the issue of emotion. My emotion, to be specific. I stated that it most likely would be in my best interest to get out of the stock since there really weren't many catalysts coming up in 2009 to propel the stock higher.

In fact, it would be easy to make the argument that, since the market has been so haywire and irrational, one must take profits when one has a profit to indeed take. Marvel is just such a stock in my portfolio. I have several paper losses, but Marvel retains its green status on my board. I love the company's story on a long-term basis, absolutely adore it, but I think it is incumbent upon every trade and investor to build a cash stash that can be used for opportunities the market may throw their way.

The Marvel position that I liquidated on Tuesday was one I owned for quite a while. It had a nice profit attached to it. I feel good about preserving that capital, especially since Marvel is lower today (at least, it's lower as I write this; as we all know, that could change in a heartbeat).

Continue reading I'm out of Marvel Entertainment

I'm out of Marvel Entertainment originally appeared on BloggingStocks on Wed, 19 Nov 2008 15:30:00 EST. Please see our terms for use of feeds.

Continue reading Closing Bell: Dow ends 2.4% down; DDS, HUM, HUN, THOR, VZ

Closing Bell: Dow ends 2.4% down; DDS, HUM, HUN, THOR, VZ originally appeared on BloggingStocks on Mon, 27 Oct 2008 16:18:00 EST. Please see our terms for use of feeds.